In the Boardroom - UK

Filter

Current filters:

UK

Popular Filters

Kymab strengthens management team with two senior appointments

Kymab strengthens management team with two senior appointments

03-06-2014

UK-based monoclonal antibody biopharmaceutical company Kymab has announced the appointment of Steve Arkinstall…

BiotechnologyBoardroomKymabPharmaceuticalUK

Summit appoints Leopoldo Zambeletti as Non-Executive Director

Summit appoints Leopoldo Zambeletti as Non-Executive Director

30-05-2014

UK-based drug discovery and development company Summit has announced the appointment of Leopoldo Zambeletti…

BiotechnologyBoardroomSummit PharmaceuticalsUK

Ario Pharma strengthens scientific advisory board with two key appointments

Ario Pharma strengthens scientific advisory board with two key appointments

12-05-2014

UK-based biopharmaceutical company Ario Pharma has announced the appointment of Professor Peter Barnes…

BiotechnologyBoardroomPharmaceuticalRespiratory and PulmonaryUK

Rolf Stahel joins Ergomed as Non-Executive Chairman

Rolf Stahel joins Ergomed as Non-Executive Chairman

07-05-2014

UK-based drug development services company Ergomed has announced the appointment of Rolf Stahel to its…

BiotechnologyBoardroomErgomed Clinical ResarchPharmaceuticalUKUSA

Cobra Biologics appoints Daniel Smith as CSO

Cobra Biologics appoints Daniel Smith as CSO

07-05-2014

Cobra Biologics is pleased to announce the appointment of Daniel Smith as Chief Scientific Officer with…

BiotechnologyBoardroomCobra BiologicsUK

GW Pharmaceuticals appoints Kenneth Sommerville as VP, Clinical Science

GW Pharmaceuticals appoints Kenneth Sommerville as VP, Clinical Science

07-05-2014

UK-based GW Pharmaceuticals has announced the appointment of Kenneth Sommerville to the newly created…

BoardroomGW PharmaceuticalsPharmaceuticalUKUSA

Sally Adams to join Scancell as Development Director

Sally Adams to join Scancell as Development Director

01-05-2014

UK-based cancer therapeutics firm Scancell has announced the appointment of Sally Adams to the board…

BiotechnologyBoardroomScancellUK

Professor Raymond Schinazi joins Board of reViral as Non-executive Director

Professor Raymond Schinazi joins Board of reViral as Non-executive Director

28-04-2014

UK-based antiviral drug discovery and development company reViral has announced the appointment of Professor…

Anti-viralsBiotechnologyBoardroomPharmaceuticalreViralUK

Novartis Vaccines appoints new Medical Affairs Director for North Europe

Novartis Vaccines appoints new Medical Affairs Director for North Europe

25-04-2014

Novartis Vaccines, the vaccination branch of Swiss drug major Novartis (NOVN: VX), has announced the…

BiotechnologyBoardroomNovartisPharmaceuticalUKVaccines

ReNeuron Group announce recruitment for new Chief Executive

ReNeuron Group announce recruitment for new Chief Executive

23-04-2014

UK-based stem cell therapy company ReNeuron Group has announced the recruitment for a new Chief Executive…

BiotechnologyBoardroomReNeuronUK

Adaptimmune announces appointment of James Noble as Chief Executive Officer

Adaptimmune announces appointment of James Noble as Chief Executive Officer

26-03-2014

Adaptimmune, a biotech company focused on the use of engineered T cells to treat cancer, has announced…

AdaptimmuneBiotechnologyBoardroomImmunocoreUK

Angle appointments new Scientific Adviser

Angle appointments new Scientific Adviser

26-03-2014

Angle (AIM:AGL), the specialist medtech company, has appointed Clive Stanway as a Scientific Adviser…

AngleBiotechnologyBoardroomCancer Research TechnologyOncologyUK

NeRRe Therapeutics announces appointment of Ian Nicholson as Chief Business Officer

NeRRe Therapeutics announces appointment of Ian Nicholson as Chief Business Officer

19-03-2014

UK-based company NeRRe Therapeutics, which is focused on the development of neurokinin (NK) receptor…

BoardroomNeRReTherapeuticsPharmaceuticalUK

Celgene UK and Ireland appoint Rob Moore as Inflammation and Immunology Business Unit Director

Celgene UK and Ireland appoint Rob Moore as Inflammation and Immunology Business Unit Director

19-03-2014

Celgene UK and Ireland have announced the appointment of Rob Moore as the new Inflammation and Immunology…

BiotechnologyBoardroomCelgeneNorthern EuropeUK

Australian Clinical Network Services opens new UK office and expands core services

10-03-2014

Australian product development company Clinical Network Services (CNS) has launched a new UK office headed…

AustraliaBiotechnologyBoardroomUK

Avillion appoints CMO Allison Jeynes-Ellis as chief executive

Avillion appoints CMO Allison Jeynes-Ellis as chief executive

18-02-2014

UK-based drug development company Avillion LLP has appointed Allison Jeynes-Ellis as chief executive.

BoardroombosutinibPharmaceuticalUK

Heptares appoints former GSK research head Tim Tasker as CMO

Heptares appoints former GSK research head Tim Tasker as CMO

10-01-2014

UK-based drug company Heptares Therapeutics has appointed Tim Tasker as chief medical officer and vice…

BoardroomHeptares TherapeuticsPharmaceuticalUK

Kemal Malik appointed Bayer board member with responsibility for innovation

Kemal Malik appointed Bayer board member with responsibility for innovation

20-12-2013

The supervisory board of German drugs and chemicals major Bayer (BAYN: DE) has appointed Kemal Malik…

BayerBiotechnologyBoardroomGermanyPharmaceuticalUK

FT Pharma 2013: AstraZeneca CEO Pascal Soriot on Brilinta, MedImmune and the UK’s ‘Golden Triangle’

FT Pharma 2013: AstraZeneca CEO Pascal Soriot on Brilinta, MedImmune and the UK’s ‘Golden Triangle’

03-12-2013

The UK’s ‘Golden Triangle’ of biotech innovation can compete on the world stage, AstraZeneca (LSE:…

AstraZenecaBoardroomBrilintaInterviewsPharmaceuticalUK

Jonathan Knowles named as executive chairman of the board of Immunocore and Adaptimmune

Jonathan Knowles named as executive chairman of the board of Immunocore and Adaptimmune

20-11-2013

UK-based biotech company Immunocore has appointed Jonathan Knowles as the new executive chairman of the…

AdaptimmuneBoardroomEuropeImmunocoreOncologyPharmaceuticalUK

Vectura appoints ex-AstraZeneca VP Bruno Angelici as non-executive chairman

Vectura appoints ex-AstraZeneca VP Bruno Angelici as non-executive chairman

20-11-2013

UK-based developer of inhaled therapies Vectura Group (LSE: VEC) has announced the appointment of Bruno…

BoardroomEuropeUKVectura

Interview: Clinigen’s CEO Peter George on the company’s record growth

Interview: Clinigen’s CEO Peter George on the company’s record growth

15-11-2013

If there is one pharma company bucking the trend of shaky financial results it is the Clinigen Group.

BoardroomClinigen GroupFoscavirInterviewsOncologyPharmaceuticalRare diseasesUK

Back to top